(RHT) Reliq Health Technologies - Ratings and Ratios
Exchange: V •
Country: Canada •
Currency: CAD •
Type: Common Stock •
ISIN: CA75955T1030
RHT EPS (Earnings per Share)
RHT Revenue
Description: RHT Reliq Health Technologies
Reliq Health Technologies Inc., a healthcare technology company, develops secure telemedicine and virtual care solutions for the healthcare market. It offers iUGO Care platform, a software as a solution that allows complex patients to receive care in the home. The company was formerly known as Moseda Technologies Inc. and changed its name to Reliq Health Technologies Inc. in May 2016. Reliq Health Technologies Inc. was incorporated in 2005 is headquartered in Hamilton, Canada., Web URL: https://www.reliqhealth.com
Additional Sources for RHT Stock
RHT Stock Overview
| Market Cap in USD | 34m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Technology |
| IPO / Inception |
RHT Stock Ratings
| Growth Rating | -26.1 |
| Fundamental | 20.4 |
| Dividend Rating | 0.0 |
| Rel. Strength | 7.46 |
| Analysts | - |
| Fair Price Momentum | 0.20 CAD |
| Fair Price DCF | - |
RHT Dividends
Currently no dividends paidRHT Growth Ratios
| Growth Correlation 3m | 0% |
| Growth Correlation 12m | 0% |
| Growth Correlation 5y | -62.2% |
| CAGR 5y | -3.73% |
| CAGR/Max DD 5y | -0.04 |
| Sharpe Ratio 12m | |
| Alpha | -4.20 |
| Beta | 0.000 |
| Volatility | 0.01% |
| Current Volume | 0k |
| Average Volume 20d | 0k |
| Stop Loss | 0.2 (-9.1%) |
What is the price of RHT shares?
As of July 15, 2025, the stock is trading at CAD 0.22 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.00%, over three months by +0.00% and over the past year by +0.00%.
As of July 15, 2025, the stock is trading at CAD 0.22 with a total of 0 shares traded.
Over the past week, the price has changed by +0.00%, over one month by +0.00%, over three months by +0.00% and over the past year by +0.00%.
Is Reliq Health Technologies a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, Reliq Health Technologies is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.38 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RHT is around 0.20 CAD . This means that RHT is currently overvalued and has a potential downside of -9.09%.
Neither. Based on ValueRay´s Fundamental Analyses, Reliq Health Technologies is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.38 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RHT is around 0.20 CAD . This means that RHT is currently overvalued and has a potential downside of -9.09%.
Is RHT a buy, sell or hold?
Reliq Health Technologies has no consensus analysts rating.
Reliq Health Technologies has no consensus analysts rating.
What are the forecasts for RHT share price target?
According to our own proprietary Forecast Model, RHT Reliq Health Technologies will be worth about 0.2 in July 2026. The stock is currently trading at 0.22. This means that the stock has a potential downside of -4.55%.
According to our own proprietary Forecast Model, RHT Reliq Health Technologies will be worth about 0.2 in July 2026. The stock is currently trading at 0.22. This means that the stock has a potential downside of -4.55%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 1.8 | 695.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.2 | -4.5% |